Physician profile
John C Bauers
NPI 1942297122
$948.61
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $82.81 · 2021: $197 · 2022: $166 · 2023: $116 · 2024: $39.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $159.82 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $142.60 | 2021-2024 | Belbuca, Xtampza |
| Mdd US Operations, LLC | $97.84 | 2019-2020 | |
| Abbvie INC. | $90.18 | 2021-2023 | Vraylar |
| Orexo US, INC. | $64.86 | 2021-2022 | |
| Pfizer INC. | $58.35 | 2019 | |
| Glaxosmithkline, LLC. | $40.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.92 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.97 | 2019 | |
| Indivior INC. | $24.55 | 2022 | |
| Genentech USA, INC. | $19.06 | 2019 | |
| Redhill Biopharma INC. | $16.93 | 2021 | |
| Abbott Laboratories | $16.08 | 2023 | Freestyle Libre 3 |
| Seqirus USA INC | $16.05 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.23 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.65 | 2019 | |
| Ibsa Pharma INC. | $14.60 | 2023 | Tirosint, Licart |
| Horizon Therapeutics Plc | $14.07 | 2021 | |
| Novo Nordisk INC | $13.58 | 2019 | |
| Alfasigma USA, INC. | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bauers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.